cell death pathways, respectively has contributed to ongoing efforts to develop subunit-selective NMDAR antagonists

cell death pathways, respectively has contributed to ongoing efforts to develop subunit-selective NMDAR antagonists. conditions. Monoclonal antibody therapies have several desirable attributes over traditional small… Read More »cell death pathways, respectively has contributed to ongoing efforts to develop subunit-selective NMDAR antagonists

We investigated the cytokine production induced by 2-Glycoprotein I in activated T cells that infiltratein vivoatherosclerotic lesions of lupus-antiphospholipid syndrome patients

We investigated the cytokine production induced by 2-Glycoprotein I in activated T cells that infiltratein vivoatherosclerotic lesions of lupus-antiphospholipid syndrome patients. and Fas/FasLigand-mediated-cytotoxicity. Altogether, our… Read More »We investigated the cytokine production induced by 2-Glycoprotein I in activated T cells that infiltratein vivoatherosclerotic lesions of lupus-antiphospholipid syndrome patients

Individuals with less severe disease following secondary DENV2 illness maintained constant levels of antibody avidity over time

Individuals with less severe disease following secondary DENV2 illness maintained constant levels of antibody avidity over time. 18 months post-illness using a urea enzyme-linked immunosorbent… Read More »Individuals with less severe disease following secondary DENV2 illness maintained constant levels of antibody avidity over time